Symbol | Exchange | Currency |
|---|
Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, today announced the pricing of its underwritten public offering of 3,048,522 shares...
Prelude Therapeutics Incorporated (“Prelude” or the “Company”) (Nasdaq: PRLD), a clinical-stage precision oncology company, today announced that it has commenced an underwritten...
PD profiles of these molecules, our….
Prelude Therapeutics Inc. is a clinical-stage fully integrated oncology company built on a foundation of drug discovery to deliver novel precision cancer medicines to underserved patients. Its CDK9 program is an essential regulator of cancer-promoting transcriptional programs, including MCL1, MYC and MYB. The Company’s product candidates include PRT1419, PRT2527, PRT3789, and PRT3645. PRT1419 is designed to be a potent and selective inhibitor of the anti-apoptotic protein, MCL1. PRT2527 is a potent and highly selective CDK9 inhibitor. PRT2527 treatment demonstrated robust efficacy in both hematological malignancies and solid tumor models with MYC. PRT3645 is a next-generation CDK4/6 inhibitor. PRT3789 is an IV-administered SMARCA2 degrader. Its pipeline consists of multiple distinct programs spanning methyltransferases, kinases, protein-protein interactions, and targeted protein degraders.
| Average | 10.75 (+94.39% Upside) |
| High | 17.00 |
| Low | 6.00 |
| Price | 5.53 |
| No. of Analysts | 4 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 124.00 | 0.00 | 0.00 | 0.00 | 0.00% | 0.00 | London | |||
| 56.50 | 56.50 | 56.50 | 0.00 | 0.00% | 0.00 | London | |||
| 101.00 | 101.00 | 101.00 | 0.00 | 0.00% | 0.00 | London | |||
| 2.00 | 2.00 | 2.00 | 0.00 | 0.00% | 0.00 | London | |||
| 115.00 | 115.00 | 115.00 | 0.00 | 0.00% | 0.00 | London | |||
| 84.25 | 84.75 | 82.00 | 0.00 | 0.00% | 0.00 | London | |||
| 87.20 | 87.00 | 86.00 | +1.00 | +1.16% | 155.56K | London | |||
| 4.66 | 4.94 | 4.66 | -0.08 | -1.69% | 16.63K | London | |||
| 1,745.50 | 1,774.00 | 1,740.50 | -12.5 | -0.71% | 245.92K | London | |||
| 9.62 | 9.62 | 9.62 | 0.00 | 0.00% | 0.00 | London | |||
| 10.00 | 10.25 | 10.25 | 0.00 | 0.00% | 0.00 | London | |||
| 155.50 | 155.50 | 155.50 | 0.00 | 0.00% | 0.00 | London | |||
| 2.34 | 2.34 | 2.34 | +0.04 | +1.74% | 142.83K | London | |||
| 0.20 | 0.20 | 0.20 | 0.00 | 0.00% | 0.00 | London | |||
| 176.85 | 176.85 | 176.85 | +1.60 | +0.91% | 14.54K | London |